{"version":"1.0","provider_name":"Neuraxpharm SE","provider_url":"https:\/\/www.neuraxpharm.com\/se","author_name":"Jaime Fern\u00e1ndez","author_url":"https:\/\/www.neuraxpharm.com\/se\/author\/jaime\/","title":"LLU\u00cdS P\u00c9REZ","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"kPW0KFJsSi\"><a href=\"https:\/\/www.neuraxpharm.com\/se\/about-us\/executive-committee\/lluis-perez\/\">LLU\u00cdS P\u00c9REZ<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.neuraxpharm.com\/se\/about-us\/executive-committee\/lluis-perez\/embed\/#?secret=kPW0KFJsSi\" width=\"600\" height=\"338\" title=\"\u201dLLU\u00cdS P\u00c9REZ\u201d &ndash; Neuraxpharm SE\" data-secret=\"kPW0KFJsSi\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.neuraxpharm.com\/se\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"https:\/\/www.linkedin.com\/in\/lluis-perez-796bb934\/ Neuraxpharm LLU\u00cdS P\u00c9REZ Llu\u00eds joined Neuraxpharm as Chief Financial Officer (CFO) in April 2018. His professional background and expertise are focused on the fields of finance and corporate finance control, including extensive international experience within large multinational companies. For more than eight years, Llu\u00eds developed his professional career as Group CFO in various business [&hellip;]","thumbnail_url":"https:\/\/www.neuraxpharm.com\/se\/wp-content\/uploads\/sites\/29\/2023\/03\/lluis-perez.jpg"}